| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Mullen, Peter
University of St Andrews
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (1/1 displayed)
Places of action
| Organizations | Location | People |
|---|
article
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models
Abstract
<p>Triplenegative,resistantormetastaticdiseasearemajorfactorsinbreastcancer mortality, warranting novel approaches. Carbonic anhydrase IX (CAIX) is implicated in survival, migration and invasion of breast cancer cells and inhibition provides an innovative therapeutic strategy. The efficacy of 5 novel ureido-substituted sulfamate CAIXinhibitorswereassessedinincreasinglycomplexbreastcancermodels, including cell lines in normoxia and hypoxia, 3D spheroids and an <em>ex-vivo</em> explant modelutilizingfreshbiopsytissuefromdifferentbreastcancersubtypes.CAIXexpression was evaluated in a tissue microarray (TMA) of 92 paired lymph node and primary breast cancers and 2 inhibitors were appraised <em>in vivo</em>using MDA-MB-231 xenografts.FC11409B,FC9398A,FC9403,FC9396AandS4decreasedcell proliferation and migration and inhibited 3D spheroid invasion. S4, FC9398A and FC9403Ainhibitedorpreventedinvasionintocollagen.FC9403A significantly reversedestablishedinvasionwhilstFC9398AandDTP348reducedxenograft growth. TMA analysis showed increased CAIX expression in triplenegative cancers.These data establish CAIX inhibition as a relevant therapeutic goal in breast cancer, targeting the migratory, invasive, and metastatic potential of this disease. The use of biopsy tissue suggests efficacy against breast cancer subtypes,and should provide a useful tool in drug testing against invasive cancers.</p>